“On behalf of the entire MediPines team, we are honored to be recognized by the judges of the MDEA for our MediPines AGM100,” said Steve lee, CEO of MediPines. “The ultimate goal in the design and engineering of this respiratory solution was to improve clinical workflow efficiency and patient outcomes. We essentially bring the lung lab to the bedside.”
To be selected as a finalist for the MDEA is a prestigious honor. Finalists are selected by a panel of industry experts, including designers, engineers and clinicians. The MediPines AGM100 was selected as a finalist in the “Diagnostic and Test Products and Systems” category. It also represents the second major recognition for MediPines in recent months, after being honored by MD Tech Review in December 2020.
The MediPines AGM100 was co-invented by Steve lee and world-renowned respiratory scientist Dr. John B West. It is the world’s first portable non-invasive gas exchange analyzer. It allows rapid detection of a patient’s respiratory status and provides a comprehensive panel of twelve respiratory measurements, including blood oxygen levels, oxygen deficit (Aa gradient), P / F ratio and alveolar oxygen and carbon dioxide levels. Much of the innovation is in ease of information: rather than having to draw blood from a patient, this portable point-of-care device simply uses a 90-second breath sample of the patient that is independent of the patient’s effort. In other words, the device works with any patient who is simply breathing normally. This innovation has already led to improved patient outcomes in hospitals where it has been adopted, especially those focusing on the impact of COVID-19 or pre-existing respiratory illnesses.
MDEA winners and MD + DI Readers’ Choice winners will be announced on May 13, during the Medtech Design Summit. To vote for the “AGM100” MediPines, click on: https://www.surveymonkey.com/r/NZD3ZRS
MediPines Corporation is a market leader in respiratory assessment and pulmonary gas exchange monitoring. The founding mission of the company is to advance respiratory medicine.